Tag: Eylea
Bayer: Positive results with Eylea in ophthalmology
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Novartis: Positive data for an Eylea biosimilar
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Novartis: positive data for an Eylea biosimilar
(CercleFinance.com) – Sandoz, a subsidiary of Novartis in the process of being spun off, announces the positive results of the Phase III efficacy and safety confirmation study MYLIGHT for its…
Bayer: positive CHMP opinion on Eylea
(CercleFinance.com) – Bayer announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for an extension of indication…